SDF2L1

SDF2L1 is an ER-resident, stress-inducible chaperone co-factor that operates within the BiP/ERdj3 chaperone cycle to suppress aggregation of misfolded ER client proteins and govern their disposal (PMID:11162531, PMID:28597544). First identified as a tunicamycin- and calcium-ionophore-inducible ER luminal protein bearing a C-terminal HDEL retention motif and similarity to the Pmt/rt O-mannosyltransferase family (PMID:11162531), it forms a stable complex with the J-domain protein ERdj3 (DNAJB11), incorporating two SDF2L1 molecules per ERdj3 dimer; this complex binds non-native proteins and inhibits their aggregation more potently than ERdj3 alone, and can hold denatured substrate in a soluble oligomeric state independently of transfer to BiP (PMID:28597544, PMID:31624144). SDF2L1 also retains ERdj3 in the ER, preventing its secretion (PMID:31624144). Functionally, SDF2L1 associates with GRP78/BiP and ERAD machinery and retards degradation of misfolded substrates such as mutant proinsulin, buffering substrate availability to extend the window for refolding (PMID:23444373), and controls ERAD through physical interaction with the cargo receptor TMED10 downstream of XBP-1s transcriptional induction, a circuit whose hepatic disruption produces sustained ER stress, insulin resistance, and fatty liver in mice (PMID:30814508). Together with SDF2, SDF2L1 is an essential, interchangeable co-factor required for DNAJB11-dependent processing of Polycystin-1 (PMID:41109348). Beyond the ER, SDF2L1 has been linked to KPNA3-dependent nuclear import of TFEB/CREB in Schwann cells (PMID:40294738) and to regulation of cellular O-mannosyltransferase content and protein O-mannosylation profiles (PMID:41781544).

1. 2001 Medium

   Established SDF2L1 as a bona fide ER stress-response gene by showing its induction is specific to ER stressors and that it carries an ER-retention signal, framing it as a candidate ER quality-control factor.

   Evidence Northern blot and sequence analysis after tunicamycin/A23187/cycloheximide treatment of murine hepatoma cells

   PMID:11162531

   Open questions at the time

   • No protein partners identified
   • Functional role beyond stress induction not tested
   • O-mannosyltransferase similarity not functionally validated
2. 2008 Medium

   Provided the first physical interactors of SDF2L1, showing it binds defensin propeptides through distinct domains, hinting at a chaperone/sorting role for secreted client proteins.

   Evidence Yeast two-hybrid screen with proRTD1a bait plus domain mapping

   PMID:19109254

   Open questions at the time

   • Y2H interactions not validated in mammalian ER
   • No functional consequence on defensin maturation shown
   • Single screen without reciprocal validation
3. 2013 High

   Connected SDF2L1 to the BiP/ERAD axis by showing it binds GRP78/BiP, ERAD machinery, and a misfolded substrate, and that its loss accelerates substrate degradation — establishing it as a buffer of ERAD substrate availability.

   Evidence Reciprocal Co-IP and SDF2L1 knockdown with pulse-chase degradation assays in INS-1 β-cells expressing insulin-C96Y-GFP

   PMID:23444373

   Open questions at the time

   • Direct vs indirect nature of BiP/ERAD interactions not dissected
   • ERdj3 not yet identified as the central partner
   • Mechanism of substrate retention unresolved
4. 2017 High

   Defined the core mechanism: SDF2L1 forms a stable ER-luminal complex with ERdj3/DNAJB11 that binds non-native proteins and inhibits aggregation as part of the BiP cycle, with substrate release dependent on ERdj3-BiP interaction.

   Evidence Co-IP, in vitro aggregation assays, dominant-negative ERdj3 mutant, subcellular fractionation

   PMID:28597544

   Open questions at the time

   • Stoichiometry of the complex not yet determined
   • Whether anti-aggregation requires BiP transfer unclear
   • Structural basis of binding unknown
5. 2019 High

   Resolved complex architecture and an autonomous chaperone function: two SDF2L1 molecules bind each ERdj3 dimer, retain ERdj3 in the ER, and confer aggregation suppression that exceeds ERdj3 alone and is independent of substrate transfer to BiP.

   Evidence In vitro reconstitution with denatured GST, stoichiometry analysis, cell-based secretion assays

   PMID:31624144

   Open questions at the time

   • High-resolution structure of the complex absent
   • Range of physiological clients not mapped
   • Interplay with the BiP cycle in vivo not fully defined
6. 2019 High

   Placed SDF2L1 in a physiological ERAD/metabolic circuit by identifying TMED10 as a partner and XBP-1s as its transcriptional regulator, with in vivo rescue demonstrating causal contribution to hepatic ER stress and metabolic disease.

   Evidence Co-IP (Sdf2l1-TMED10), liver-specific knockdown/rescue in mice with metabolic phenotyping, XBP-1s overexpression

   PMID:30814508

   Open questions at the time

   • Mechanistic link between TMED10 binding and ERAD output not detailed
   • Relationship between TMED10 and ERdj3 complexes unresolved
   • Human relevance not established
7. 2025 High

   Demonstrated functional essentiality and redundancy of SDF2L1 with its paralog SDF2 as DNAJB11 co-factors required for processing of a defined client, Polycystin-1.

   Evidence Interaction proteomics, single/double CRISPR knockouts, PC1 processing Western blots, individual re-expression rescue

   PMID:41109348

   Open questions at the time

   • Biochemical step in PC1 processing that requires the complex undefined
   • Generality across other DNAJB11 clients untested
   • Basis of SDF2/SDF2L1 reciprocal abundance dependence unknown
8. 2025 Medium

   Extended SDF2L1 function beyond the ER lumen, linking it to KPNA3-dependent nuclear import of TFEB/CREB and downstream autophagy/neurotrophin programs in Schwann cells.

   Evidence RNA-seq/proteomics, SDF2L1 KD/KO in RSC96 and primary Schwann cells, KPNA3 overexpression rescue, nuclear fractionation, in vivo KO mice electrophysiology

   PMID:40294738

   Open questions at the time

   • Mechanism linking ER chaperone SDF2L1 to cytosolic KPNA3 levels unexplained
   • Direct vs indirect regulation of KPNA3 not resolved
   • Single lab
9. 2026 Medium

   Connected SDF2L1 to the O-mannosylation machinery, showing it positively regulates O-mannosyltransferase content and shapes cellular O-mannosylation profiles.

   Evidence CRISPR Sdf2l1 KO mice, LC-MS/MS glycoproteomics, ELISA for O-mannosyltransferase, KD/OE cell lines

   PMID:41781544

   Open questions at the time

   • Whether SDF2L1 directly stabilizes POMT enzymes or acts indirectly unknown
   • Functional consequence of altered TLR4/MCM8 O-mannosylation not established
   • Single lab

• How SDF2L1's ER-luminal chaperone activity mechanistically connects to its reported cytosolic/nuclear (KPNA3-TFEB/CREB) and O-mannosylation roles, and the structural basis of client engagement, remain open.
• No structure of the ERdj3-SDF2L1 complex
• No unifying mechanism linking ER and non-ER functions
• Human disease causation not established in the corpus